跳至主要内容
临床试验/ACTRN12613000323729
ACTRN12613000323729已完成4 期

The Tranexamic Acid in Lower Limb Arthroplasty Pilot Trial - a pilot trial to examine the feasibility of extension of trial methodology to a large multi-centre randomised controlled trial.

Royal Adelaide Hospital0 个研究点目标入组 140 人开始时间: 2013年3月22日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
45 Years 至 o limit(—)
性别
All

入选标准

  • >45 years of age
  • Undergoing primary or revision total knee or hip replacement
  • At least one night inpatient stay

排除标准

  • Poor English language comprehension
  • Inability to obtain informed consent
  • Active thrombo-embolic disease such as DVT, PE, or cerebral thrombosis
  • History of postoperative or spontaneous DVT, pulmonary embolism, spontaneous arterial thrombosis or familial hypercoagulability
  • End-stage renal failure
  • Recent haematuria
  • Contraindication or allergy to TXA
  • Patients who have received TXA or DDAVP in the last 7 days
  • Oral contraceptive (other than low dose Progesterone only)

研究者

相似试验